tiprankstipranks
BioHarvest Sciences (TSE:BHSC)
CNQX:BHSC

BioHarvest Sciences (BHSC) Stock Price & Analysis

24 Followers

BHSC Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.14 - C$0.30
Previous CloseC$0.24
Volume173.59K
Average Volume (3M)87.57K
Market Cap
C$114.89M
Enterprise ValueC$128.38M
Total Cash (Recent Filing)$1.56M
Total Debt (Recent Filing)$11.43M
Price to Earnings (P/E)-5.6
Beta0.57
May 29, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding478,688,168
10 Day Avg. Volume84,372
30 Day Avg. Volume87,569
Standard Deviation0.23
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-11.63
Price to Sales (P/S)47.01
Price to Cash Flow (P/CF)-22.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue12.12
Enterprise Value/Gross Profit52.49
Enterprise Value/Ebitda-30.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

36.20%0.00%0.00%63.80%
36.20% Insiders
0.00% Other Institutional Investors
63.80% Public Companies and
Individual Investors

BHSC FAQ

What was BioHarvest Sciences’s price range in the past 12 months?
BioHarvest Sciences lowest stock price was C$0.14 and its highest was C$0.30 in the past 12 months.
    What is BioHarvest Sciences’s market cap?
    Currently, no data Available
    When is BioHarvest Sciences’s upcoming earnings report date?
    BioHarvest Sciences’s upcoming earnings report date is May 29, 2024 which is in 19 days.
      How were BioHarvest Sciences’s earnings last quarter?
      Currently, no data Available
      Is BioHarvest Sciences overvalued?
      According to Wall Street analysts BioHarvest Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does BioHarvest Sciences pay dividends?
        BioHarvest Sciences does not currently pay dividends.
        What is BioHarvest Sciences’s EPS estimate?
        BioHarvest Sciences’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does BioHarvest Sciences have?
        BioHarvest Sciences has 478,688,170 shares outstanding.
          What happened to BioHarvest Sciences’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of BioHarvest Sciences?
          Currently, no hedge funds are holding shares in TSE:BHSC
          ---

          Company Description

          BioHarvest Sciences

          BioHarvest Sciences Inc is the developer and owner of the proprietary and patent protected Biofarming technology. It is the industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. The technology has been already validated by Vinia, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest. By adapting this technology to the Cannabis plant, and building adequate cells production capacity, the company's objective is to be the supplier of Cannabis for both the medicinal and recreational legal use.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Reliq Health Technologies
          Tetra Bio-Pharma
          Neptune Wellness Solutions
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis